NYSE$IQV
IQVIA Holdings Inc. · Q3 2023 earnings
Q3 2023 earnings · · Investor relations
Briefing
IQVIA's Q3 2023 performance was driven by revenue growth and strong performance in the R&DS segment.
IQVIA reported a 4.9% year-over-year revenue increase in Q3 2023, reaching $3,736 million. Net income grew by 7.1% to $303 million, and adjusted EBITDA increased by 9.1% to $888 million. The R&DS segment demonstrated notable strength, with a book-to-bill ratio of 1.24x and backlog growth of 12%.
- IQVIA's Q3 2023 revenue reached $3,736 million, representing a 4.9% year-over-year increase.
- GAAP net income for Q3 2023 was reported as $303 million, a 7.1% increase compared to the previous year.
- The R&D Solutions segment showed strong performance with a book-to-bill ratio of 1.24x and backlog growth of 12%.
- Adjusted EBITDA for the quarter grew by 9.1% year-over-year, amounting to $888 million.
Headline financials
Revenue & EPS history
IQVIA · Revenue · Quarterly
$3.74B
Revenue by segment
IQVIA · $3.74B total across 3 segments · Q3 2023
- Research & Development Solutions$2.12B+7.2%56.8%
- Technology & Analytics Solutions$1.43B+2.2%38.3%
- Contract Sales & Medical Solutions$183M+0.0%4.9%
Forward guidance
The company updated its full-year guidance to reflect slower growth in our TAS segment and the impact of the strengthening US dollar.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2023
+1.4%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+1.9%
Avg return
30 days after
65%
37 / 57 earnings
Positive
+12.5%
Q2 2018
Best reaction
-10.7%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +7.7% | +10.9% | +13.9% | |
| Q4 2025 | -10.7% | -9.9% | -13.8% | |
| Q3 2025 | +0.3% | -0.4% | +6.6% | |
| Q2 2025 | -0.4% | +1.1% | -1.6% | |
| Q1 2025 | -4.0% | -2.2% | -3.2% | |
| Q4 2024 | +2.2% | -2.2% | -6.7% | |
| Q3 2024 | -3.2% | -1.5% | -7.0% | |
| Q2 2024 | +6.3% | +6.7% | +10.0% | |
| Q1 2024 | -4.1% | -1.6% | -5.9% | |
| Q4 2023 | +12.2% | +10.8% | +17.4% | |
| Q3 2023 | +5.3% | +9.7% | +20.0% | |
| Q2 2023 | -2.1% | -3.1% | -0.5% | |
| Q1 2023 | -0.9% | -2.3% | +5.0% | |
| Q4 2022 | +0.8% | -1.4% | -14.4% | |
| Q3 2022 | +1.4% | +6.1% | +11.3% | |
| Q2 2022 | +0.5% | -0.4% | +8.3% | |
| Q1 2022 | +6.1% | +5.0% | +6.7% | |
| Q4 2021 | -3.2% | -4.8% | -6.9% | |
| Q3 2021 | +2.1% | +1.8% | +6.6% | |
| Q2 2021 | -0.8% | +0.2% | +4.5% | |
| Q1 2021 | +6.1% | +7.0% | +9.1% | |
| Q4 2020 | +4.9% | +4.8% | +1.6% | |
| Q3 2020 | +3.2% | +2.1% | +3.4% | |
| Q2 2020 | +2.9% | +3.4% | +0.4% | |
| Q1 2020 | +8.5% | +3.5% | +10.9% | |
| Q4 2019 | +2.5% | +1.6% | -26.6% | |
| Q3 2019 | -3.8% | -2.4% | -2.7% | |
| Q2 2019 | +2.1% | +1.6% | -2.3% | |
| Q1 2019 | -2.0% | -0.1% | -2.2% | |
| Q4 2018 | +7.6% | +7.3% | +7.4% | |
| Q3 2018 | -3.5% | -5.3% | -8.4% | |
| Q2 2018 | +12.5% | +8.2% | +11.7% | |
| Q1 2018 | -0.7% | +0.2% | +2.6% | |
| Q4 2017 | +1.5% | +1.7% | +5.6% | |
| Q3 2017 | +6.1% | +6.5% | +2.7% | |
| Q2 2017 | -1.3% | -1.0% | +4.4% | |
| Q1 2017 | -3.7% | -2.0% | +3.0% | |
| Q4 2016 | -2.7% | -4.1% | +0.5% | |
| Q3 2016 | +0.8% | +4.1% | +3.3% | |
| Q2 2016 | +3.3% | +4.2% | +0.3% | |
| Q1 2016 | -5.9% | — | — | |
| Q4 2015 | +3.6% | — | — | |
| Q3 2015 | -6.2% | — | — | |
| Q2 2015 | +2.6% | — | — | |
| Q1 2015 | -4.9% | — | — | |
| Q4 2014 | +4.3% | — | — | |
| Q3 2014 | +0.9% | — | — | |
| Q2 2014 | -3.1% | — | — | |
| Q1 2014 | +0.4% | — | — | |
| Q4 2011 | +7.5% | — | — | |
| Q4 2013 | +7.5% | — | — | |
| Q3 2012 | +0.1% | — | — | |
| Q3 2013 | +0.1% | — | — | |
| Q2 2012 | +0.8% | — | — | |
| Q2 2013 | +0.8% | — | — | |
| Q1 2012 | +5.0% | — | — | |
| Q4 2012 | +5.0% | — | — | |
| Q1 2013 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro